(Q43433279)

23 November 2017

title

The HIV-1 Vpr co-activator induces a conformational change in TFIIB. (English)

1 reference

23 November 2017

Agostini I

1

1 reference

23 November 2017

Navarro JM

2

1 reference

23 November 2017

Bouhamdan M

3

1 reference

23 November 2017

Willetts K

4

1 reference

23 November 2017

Rey F

5

1 reference

23 November 2017

Spire B

6

1 reference

23 November 2017

Vigne R

7

1 reference

23 November 2017

Pomerantz R

8

1 reference

23 November 2017

Sire J

9

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

23 November 2017

number of pages

5

1 reference

inferred from page(s)

published in

FEBS Letters

1 reference

23 November 2017

volume

450

1 reference

23 November 2017

issue

3

1 reference

23 November 2017

page(s)

235-239

1 reference

HIV accessory proteins: leading roles for the supporting cast.

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

Induction of cell differentiation by human immunodeficiency virus 1 vpr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

Interaction of Virion Protein Vpr of Human Immunodeficiency Virus Type 1 with Cellular Transcription Factor Sp1 and trans-Activation of Viral Long Terminal Repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

Activator-induced conformational change in general transcription factor TFIIB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: effect on stability and virion incorporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

7 January 2021

Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

7 January 2021

Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

7 January 2021

Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

7 January 2021

Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900501-3

7 January 2021

10.1016/S0014-5793(99)00501-3

Identifiers

DOI

1 reference

23 November 2017

1 reference